SBIR/STTR Research Award

Mass Spectroscopy Tissue Imaging of Specific Cell Types Using Receptor Targeted G

Award identifier fc788d4cb1a9cd38aa5d3b03b85123bb738d5a9f1577f9a24651fcfccf3067d1Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,695

Program and phase

SBIR · Phase I

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOCOMPOSIX, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
EVQMBF7KC8P3
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Developing new strategies to treat drug addiction requires a detailed understanding of how biomolecules are up and down regulated in response to a drug dose within specific regions of an organ, such as the brain. MALDI imaging mass spectrometry is a powerful tool that can give a biomolecular image map of tissue slices at unprecedented levels of molecular detail. A principal challenge of the technique is determining what components of a tissue give rise to the vast number of biomolecule that are observed for each laser shot (i.e. pixel) in the MALDI image. Here we propose targeting nanoparticles that can function as a MALDI matrix to specific cells or cell receptors. By localizing the matrix to a specific cell type or tissue region, only biomolecules in the vicinity of the nanoparticle matrix will be detected. By eliminating the formation of biomolecular ions from non-specific components of the tissue, the complexity of the molecular signal will be dramatically reduced allowing for the detection of lower abundance biomolecules in or near cells of interest. This technique is applicable for the analysis of both in-vitro tissue analysis and in-vivo studies where the functionalized nanoparticles are introduced directly into the tissue of interest. When used in conjunction with 2D ion separation techniques such as ion mobility time-of-flight mass spectrometry, this innovative technique will generate a focused biomolecular image map that can identify the biological response to drugs of abuse and lead to a new understanding of the molecular basi of addiction. PUBLIC HEALTH RELEVANCE: MALDI imaging mass spectrometry is a tool that can create a spatial map of the complex molecular makeup of tissues. One of the challenges of this emerging technology is how to deconvolute what tissue components give rise to particular biomolecular ions that are detected at a given location. By utilizing functionalized nanoparticles as a MALDI matrix, researchers will be able to monitor changes to biomolecules in and around specific cells or regions of a tissue as a function of drug exposure. Because the MALDI- MS signal is isolated to regions where the matrix is targeted, only molecular ions near the area of interest will be identified providing a powerful method of observing changes to a particular area of a tissue.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

50 SBIR/STTR records share this UEI (2005–2020). Reported award amounts total $19,180,547. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.